Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 93 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Anastasilakis, Athanasios D [Clear All Filters]
Activin A and follistatin in patients with nonalcoholic fatty liver disease..
Metabolism. 65(10), 1550-8.
(2016). Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study..
Metabolism. 141, 155397.
(2022). Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatide..
Eur J Endocrinol. 158(3), 411-5.
(2008). Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass..
Bone. 50(5), 1130-4.
(2012). Acute transient thyroid swelling following needle biopsy: an update..
Hormones (Athens). 11(2), 147-50.
(2012). Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review..
Thyroid. 20(3), 265-71.
(2010). Apelin levels in normal pregnancy..
Clin Endocrinol (Oxf). 75(3), 367-71.
(2011). Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease..
Endocrine. 49(2), 560-2.
(2015). Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study..
Endocrine. 81(3), 573-578.
(2023). Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview..
Hormones (Athens). 18(1), 65-70.
(2019).
(2019).
Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans..
Metabolism. 65(10), 1459-65.
(2016). Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition..
J Clin Endocrinol Metab. 99(9), 3247-55.
(2014).
(2017). Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass..
J Musculoskelet Neuronal Interact. 19(3), 253-257.
(2019). Circulating periostin levels in patients with AS: association with clinical and radiographic variables, inflammatory markers and molecules involved in bone formation..
Rheumatology (Oxford). 54(5), 908-14.
(2015). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016).
(2021). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment..
Expert Opin Ther Targets. 19(3), 299-306.
(2015). Clinical complications following thyroid fine-needle biopsy: a systematic review..
Clin Endocrinol (Oxf). 71(2), 157-65.
(2009). Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases..
J Bone Miner Res. 32(6), 1291-1296.
(2017). Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature..
Metabolism. 62(10), 1350-6.
(2013). Combination and sequential treatment in women with postmenopausal osteoporosis..
Expert Opin Pharmacother. 21(4), 477-490.
(2020).
(2021).
(2013). Σελίδες
- 1
- 2
- 3
- 4
- επόμενη ›
- τελευταία »